Cairo – GlaxoSmithKline (GSK Egypt) registered an annual growth in consolidated net profit after tax to EGP 105.82 million during the first nine months (9M) of 2024, versus EGP 46.73 million.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback